Exelixis Clinical

Clinical research site in Dallas, Texas · 5959 HARRY HINES BLVD STE 820, DALLAS, TX 75235-6233 · (214) 638-1773

Part of Exelixis Clinical

As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in Dallas, Texas. Active studies at this site cover conditions such as Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD and Renal Cell Carcinoma (RCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Exelixis Clinical (2)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for Neovascular Age-Related Macular Degeneration (nAMD)

79 locations incl. Mesa

Sponsor: Adverum Biotechnologies, Inc.

Sex: All·Age: 50+

Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

44 locations incl. Phoenix

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

More research sites in Dallas

University of Texas Southwestern Medical Center (189 trials)
UT Southwestern Medical Center (168 trials)
UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
University of Texas Southwestern (63 trials)
Baylor University Medical Center (43 trials)
Medical City Dallas Hospital (26 trials)
The University of Texas Southwestern Medical Center (25 trials)
Parkland Memorial Hospital (24 trials)
Mary Crowley Cancer Research (23 trials)
UT Southwestern (23 trials)

Explore more

Paid clinical trials in Dallas, TX · Texas clinical trials